510(k) K221652
K221652 is an FDA 510(k) premarket notification submitted by Renal Care Dialysis Solutions, S.A. DE C.V. for the device "NIKKICART". The FDA issued a decision of Substantially Equivalent on March 3, 2023. The device falls under product code KPO (Dialysate Concentrate For Hemodialysis (Liquid Or Powder)), a Class II device regulated under 21 CFR 876.5820.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 3, 2023
- Date Received
- June 7, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Dialysate Concentrate For Hemodialysis (Liquid Or Powder)
- Device Class
- Class II
- Regulation Number
- 876.5820
- Review Panel
- GU
- Submission Type